Latest News
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamine for Oral Solution, Dimethyl Sulfoxide (DMSO) Irr...
FDA grants Priority Review to Genentech's Enspryng for MOGAD
10 September 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has granted Priority Review to its supplemental application for Enspryng (...
BioMarin announces positive Phase 3 VOXZOGO (vosoritide) study results in hypochondroplasia published in NEJM Evidence
10 September 2026 - Biotechnology company BioMarin Pharmaceutical Inc (Nasdaq:BMRN) announced on Wednesday that new data from the Phase 3 CANOPY-HCH-3 study evaluating VOXZOGO (vosoritide) in children with hypochondroplasia were published in New Engl...
Seismic Pharmaceuticals enrols first patient in istaroxime global Phase 3 trial in cardiogenic shock
10 September 2026 - Seismic Pharmaceuticals, a biotechnology company focused on advancing novel treatments for heart failure, announced on Wednesday the enrolment of the first patient in its global Phase 3 clinical trial evaluating istaroxime in pati...
BioEdge Research Labs advances transparency in research compound documentation
10 September 2026 - BioEdge Research Labs, a US-based supplier of research peptides and reference materials, on Wednesday announced an initiative to advance transparency in how its research materials are documented.This initiative expands researcher ...